SLRN
Acelyrin, Inc.
No insider bought or sold Acelyrin, Inc. in the last 12 months
$0Bought, 12 mo
$0Sold, 12 mo
SLRN over the last year
Prices for SLRN aren't in yet.
SLRN after insider buys
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Every filing
11 insider filings since 2023, newest first
SLRNSell
Shao-Lee Lin · CEO
$66KApr 3
SLRNSell
Shao-Lee Lin · CEO
$119KFeb 22
SLRNSell
Shao-Lee Lin · CEO
$79KJan 4
SLRNBuy
Westlake Biopartners Fund Ii, L.P. · 10% owner
$22.5M+15.0%May 11
SLRNBuy
Beth C Seidenberg · Director and 10% owner
$23.6M+15.0%May 11
SLRNBuy
Dawn Svoronos · Director
$270KMay 11
SLRNBuy
Henry O Gosebruch · Director
$900KMay 11
SLRNBuy
Daniel J. Becker · Director
$54KMay 11
SLRNBuy
Mina Kim · Chief Legal, Admin. Officer
$90KMay 11
SLRNBuy
Paul Peloso · Chief Medical Officer
$108KMay 11
SLRNBuy
Mardi Dier · CFO, CBO
$132K−835.0%May 11
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.